1. Short title This Act may be cited as the Faster Treatments and Cures for Eye Diseases Act . 2. Definitions For purposes of this Act: (1) Applicable congressional committees The term applicable congressional committees means the Committees on Energy and Commerce and Financial Services of the House of Representatives and the Committees on Banking, Housing, and Urban Affairs and Health, Education, Labor, and Pensions of the Senate. (2) Appropriate Federal banking agency The term appropriate Federal banking agency has the meaning given that term in section 3 of the Federal Deposit Insurance Act ( 12 U.S.C. 1813 ). (3) Cost The term cost has the meaning given to the term cost of a loan guarantee in section 502(5)(C) of the Federal Credit Reform Act of 1990 ( 2 U.S.C. 661a(5)(C) ). (4) Depository institution; depository institution holding company The term depository institution and depository institution holding company have the meaning given those terms under section 3 of the Federal Deposit Insurance Act ( 12 U.S.C. 1813 ). (5) Eye bond The term eye bond means a bond— (A) issued by an issuer pursuant to this Act; (B) the proceeds of which are used to fund projects selected under section 6(b)(1), except as otherwise described in this Act; and (C) that complies with the regulations issued under section 4. (6) Funded project The term funded project means a translational research project that is selected to be funded using the proceeds of an eye bond. (7) Guarantee The term guarantee has the meaning given to the term loan guarantee in section 502 of the Federal Credit Reform Act of 1990 ( 2 U.S.C. 661a ) and includes a loan guarantee commitment (as defined in such section 502). (8) Issuer The term issuer means an entity that— (A) is a depository institution, a depository institution holding company, or a broker or dealer registered with the Securities and Exchange Commission; (B) complies with the schedule for the issuance of eye bonds established under section 3(c)